Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Aylward

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Plos Medicine|October 27, 2011
A statistical model of the international spread of wild poliovirus in Africa used to predict and prevent outbreaksKathleen M O'Reilly, Claire Chauvin, R Bruce Aylward, et al.
BMC Public Health|December 10, 2020
Design thinking during a health emergency: building a national data collection and reporting systemKara N Durski, Shalini Singaravelu, Dhamari Naidoo, et al.
The Journal of Infectious Diseases|October 16, 2014
A world without polioStephen L Cochi, Hamid S Jafari, Gregory L Armstrong, et al.
Lancet (London, England)|July 7, 2012
The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysisKathleen M O'Reilly, Elias Durry, Obaid ul Islam, et al.
Vaccine|October 30, 2010
Economic analysis of the global polio eradication initiativeRadboud J Duintjer Tebbens, Mark A Pallansch, Stephen L Cochi, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradicationRadboud J Duintjer Tebbens, Mark A Pallansch, Olen M Kew, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 17, 2008
Uncertainty and sensitivity analyses of a decision analytic model for posteradication polio risk managementRadboud J Duintjer Tebbens, Mark A Pallansch, Olen M Kew, et al.
American Journal of Public Health|May 31, 2008
The risks, costs, and benefits of possible future global policies for managing poliovirusesKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
The New England Journal of Medicine|June 25, 2010
Implications of a circulating vaccine-derived poliovirus in NigeriaHelen E Jenkins, R Bruce Aylward, Alex Gasasira, et al.
The New England Journal of Medicine|February 1, 2013
Priming after a fractional dose of inactivated poliovirus vaccineSonia Resik, Alina Tejeda, Roland W Sutter, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Plos Medicine|October 27, 2011
A statistical model of the international spread of wild poliovirus in Africa used to predict and prevent outbreaksKathleen M O'Reilly, Claire Chauvin, R Bruce Aylward, et al.
BMC Public Health|December 10, 2020
Design thinking during a health emergency: building a national data collection and reporting systemKara N Durski, Shalini Singaravelu, Dhamari Naidoo, et al.
The Journal of Infectious Diseases|October 16, 2014
A world without polioStephen L Cochi, Hamid S Jafari, Gregory L Armstrong, et al.
Lancet (London, England)|July 7, 2012
The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysisKathleen M O'Reilly, Elias Durry, Obaid ul Islam, et al.
Vaccine|October 30, 2010
Economic analysis of the global polio eradication initiativeRadboud J Duintjer Tebbens, Mark A Pallansch, Stephen L Cochi, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradicationRadboud J Duintjer Tebbens, Mark A Pallansch, Olen M Kew, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 17, 2008
Uncertainty and sensitivity analyses of a decision analytic model for posteradication polio risk managementRadboud J Duintjer Tebbens, Mark A Pallansch, Olen M Kew, et al.
American Journal of Public Health|May 31, 2008
The risks, costs, and benefits of possible future global policies for managing poliovirusesKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
The New England Journal of Medicine|June 25, 2010
Implications of a circulating vaccine-derived poliovirus in NigeriaHelen E Jenkins, R Bruce Aylward, Alex Gasasira, et al.
The New England Journal of Medicine|February 1, 2013
Priming after a fractional dose of inactivated poliovirus vaccineSonia Resik, Alina Tejeda, Roland W Sutter, et al.
Pageof 7